| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Microbiology, Fukui University School of Medicine, Fukui 910-1193, Japan
2 Department of Immunology, China Medical University College of Basic Medical Sciences, Shenyang 110001, China
3 Department of Medical Technology, Gifu University of Medical Science, Gifu 501-3892, Japan
Correspondence
Yoshinobu Kimura
kimura{at}u-gifu-ms.ac.jp
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
, 2005; Dowell et al., 1996). RSV infection is associated with 10 % of elderly people hospitalized for acute cardiopulmonary condition and with 13 % hospitalized for influenza (Walsh et al., 1999). The reasons for more-severe clinical disease with RSV infection in the elderly are not well understood. Age-related immune dysregulation (Miller, 1996; Boukhvalova et al., 2007) seems likely to be the most important factor in association with infectious diseases. It has been shown that elderly people exhibit a significant deficiency in the influenza virus-specific CD8+ T-cell response when compared with young adults (Mbawuike et al., 1993). Experimentally, aged mice are more susceptible to influenza virus as well as RSV infection, exhibiting a deficiency in virus-specific cytotoxic T lymphocyte (CTL) responses with small amounts of gamma-interferon (IFN-
) but large amounts of interleukin (IL)-4 production (Mbawuike et al., 1996; Zhang et al., 2002). However, local immune responses to RSV infection in the elderly have not been well investigated. To examine the age-associated immune alteration and its influence on defence mechanisms against RSV infection, we adopted a newly developed senescence-accelerated mouse (SAM) system. The senescence-prone strain of SAM mice, SAM-P1, shows various signs of rapid ageing, such as a shortened lifespan of about half that of ordinary control mice, wrinkled skin and age-dependent geriatric disorders, including senile amyloidosis of the joints, hyperinflation of the lungs, hearing impairment and immune deficiency (Abe et al., 1994; Haruna et al., 1995). SAM-P1 mice show an age-related decline in immune responses, particularly cellular immune responses, as early as 2 months old (Toichi et al., 1997; Dong et al., 2000). These characteristics of the SAM-P1 mice are useful for animal model experiments involving virus infection among geriatric patients. In the present study, we infected SAM-P1 mice intranasally with RSV and investigated the host defence system, particularly focusing on the local immune response in the respiratory tract, as RSV infection is restricted to surface infection of the airway mucosal membrane cells but not viraemia. Age-matched parental senescence-regular SAM-R1 mice were used as a control.
|
METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
.
To inactivate the virus, an aliquot of the virus suspension was irradiated with UV light for 15 min on ice (Reuman et al., 1990). After irradiation, no infectivity could be detected.
Mice.
The senescence-prone SAM-P1 strain (H-2k), with a genetic background of AKR/J mice, and its parental senescence-regular SAM-R1 strain were obtained from the Institute for Frontier Medical Science (Kyoto University, Japan). Mice had fresh water and autoclaved food and were kept at 23 °C under conventional conditions throughout all experiments. Three-month-old SAM-P1 mice and age-matched SAM-R1 mice were used in this study. Mice were mildly anaesthetized by intraperitoneal administration of pentobarbital sodium [0.025 mg (g body weight)–1] and inoculated in the right nostril with 20 µl PBS containing 2x106 TCID50 RSV per mouse. At intervals, lung tissue was removed aseptically. Lung homogenates were prepared in a mortar using sterile sea sand and collected in 2 ml sterile PBS. After centrifugation at 1250 g for 10 min, supernatants were frozen at –80 °C until the virus titre was assayed. To avoid laboratory contamination, all virus-infected mice were housed in negatively pressurized isolators equipped with a ventilation system through a high-efficiency particulate air filter (AH model; Nihon-Ika). This work was approved by the Institutional Animal Care and Use Committee of Fukui University School of Medicine, Japan.
Preparation of single-cell suspensions from the lung parenchyma.
Mice were anaesthetized and the lung was flushed in situ with 20 ml sterile PBS via cannulation of the heart to remove the intravascular blood pool. Minced lung tissues were incubated at 37 °C for 60 min on a rocker with 200 µg collagenase D ml–1 and 40 µg DNase ml–1 (both from Roche Molecular Biochemicals) as described previously (Liu et al., 2004). Subsequently, the enzyme-digested lung tissue was passed through a stainless steel mesh. Single-cell suspensions were collected by density-gradient centrifugation with lymphocyte separation solution (Antibody Institute).
Identification of lung parenchymal cells.
Each separate aliquot of lung parenchymal cells was incubated on ice for 20 min with the following monoclonal antibodies (mAbs); phycoerythrin-labelled mAb for CD4 and fluorescein isothiocyanate-labelled mAb for CD8, CD16/32 or CD19 (Caltag Laboratory). The fluorescence intensity of cell samples was assayed on a fluorescence-activated cell sorter (EPICS XL; Beckman Coulter), acquiring 10 000 events per sample. Data were analysed using the computer program SYSTEM 2, version 1.0.
Assay of cytokine production.
Single-cell suspensions (4x105 cells in 200 µl per well) were prepared from the lung parenchyma of SAM mice and cultured for 48 h in the presence of UV-inactivated RSV antigens (equivalent to the original of 2x106 TCID50 per well). The supernatants were then harvested and assayed for IFN- and IL-4 titres using a mouse cytokine detection ELISA kit (BioSource International) in accordance with the manufacturer's instructions.
Assay of CTL activity.
A cytotoxicity assay was performed according to a protocol described previously (Liu et al., 2001). Lung parenchymal cells were collected from infected mice. Mouse L929 (H-2k) cells infected with RSV at an input m.o.i. of 1 TCID50 were used as target cells. Lymphocytes and target cells were mixed and incubated at 37 °C in a 5 % CO2 atmosphere for 4 h. Specific lysis of target cells was determined by a lactate dehydrogenase-release assay (Decker & Lohmann-Matthes, 1988) using a cytotoxic detection kit (Roche Applied Science). Data were expressed as the percentage of specific release using the following formula: cytotoxicity (%)=100x[(target with effector–effector spontaneous)–target spontaneous]/[target maximum–target spontaneous].
Assay of NK cell activity.
Lung parenchymal cells were collected 3 days after infection and co-cultured with NK-sensitive Yac-1 target cells at 37 °C for 4 h. Specific lysis of target cells was determined by a lactate dehydrogenase-release assay as described above.
Antibody assay.
Virus-specific immunoglobulins (Igs) were measured using an ELISA Ig Quantitative kit (Bethyl Laboratories). Briefly, microtitre plates were coated with 10 µg purified RSV proteins overnight at 4 °C. After blocking with 1 % BSA for 30 min, bronchoalveolar lavage (BAL) fluids were added to the well and incubated for 1 h. Bound antibodies were reacted with goat horseradish peroxidase-labelled anti-mouse IgG1, IgG2a or IgA. Plates were read at 450 nm after the addition of 3,3',5,5'-tetramethylbenzidine. Antibody titres were calculated using a standard curve that was determined from the reference serum using the calculation software SPECTRA MAX 250 (Molecular Devices).
Adoptive transfer of spleen cells.
Spleen cells were obtained from 6-week-old C3H/HeJ (H-2k) mice, and 5.0x107 cells in 0.2 ml were transferred intravenously into SAM-P1 (H-2k) mice immediately after they had been infected intranasally with an inoculum dose of 2.0x106 TCID50 RSV per mouse.
Statistical significance.
The two-tailed Mann–Whitney U-test and Student's t-test were used to determine whether a significant difference (P<0.05) existed between SAM-P1 and control SAM-R1 mice.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). SAM-P1 mice experienced a weight loss of up to 14 % of their pre-infection weight at day 10 after infection. In contrast, the weight loss of SAM-R1 mice was less than 6 %. Recovery from weight loss in SAM-P1 mice was slow and delayed over 20 days after infection, whilst SAM-R1 mice gained the pre-infection weight quickly. The infected SAM-P1 mice showed sluggish movement and anorexia, and became emaciated. No cases of death were observed in either SAM-P1 or SAM-R1 mice under the experimental conditions used.
|
). Control SAM-R1 mice completely cleared the virus from the lungs by day 8. These results suggested that SAM-P1 mice bore some defects in the defence system against RSV infection.
|
). Following virus infection, a large number of cells infiltrated the lungs of SAM-P1 mice and were retained there for a long period of over 12 days after infection, whilst in the control SAM-R1 mice, infiltrated cells rapidly returned to the normal level (Fig. 3). A major population of cells that appeared in SAM-P1 mice was CD16+/32+ lymphocytes. It should be noted that SAM-P1 mice showed a decreased proportion of lymphocytes and an increased proportion of granulocytes. The proliferation of CD4+ and CD8+ T lymphocytes in response to RSV infection may be deficient in aged mice (Zhang et al., 2002). No significant difference was observed in the number of CD19+ B cells between the two strains of SAM mice (Table 1).
|
|
). Induction of a virus-specific CTL response to RSV infection was impaired in SAM-P1 mice compared with that in SAM-R1 mice at each time point indicated (Fig. 4a). NK cell activity in SAM-P1 mice was also confined to a low level (Fig. 4b). Thus, the impaired cellular immunity to RSV infection in the lungs of SAM-P1 mice was inferred to be associated with elevated virus growth and prolonged virus shedding.
|
). The production of mucosal IgA antibody in SAM-P1 mice was restrained when compared with that of SAM-R1 mice (P<0.05) (Fig. 5c). However, no statistical difference mice was detected in the antibody titres of IgG1 and IgG2a between SAM-P1 and SAM-R1 mice (Fig. 5a, b).
|
). A significantly high titre of IFN-, a T-helper type 1 (Th1) cytokine, was detected in the lungs of control SAM-R1 mice, whilst, in SAM-P1 mice, the production of IFN- was restrained and delayed until 9 days after infection. Interestingly, SAM-P1 mice produced much higher amounts of IL-4, a Th2 cytokine, after RSV infection. These findings indicated that the local immune responses in SAM-P1 mice appeared to shift towards a Th2-type dominance.
|
). The transfer of immune-competent spleen cells of C3H/HeJ mice effectively eradicated the challenge virus from the lungs. This suggested that cell-mediated immunity plays a critical role in the defence system against RSV infection.
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
). Children with defects in cell-mediated immunity have difficulty eradicating RSV and exhibit severe lung infections, implying that the T-cell population is an important immune component in controlling RSV infection (Hall et al., 1986; de Bree et al., 2005). In fact, CTL and NK cells showed low titres in SAM-P1 mice (Fig. 4
), and the transfer of immune-competent spleen cells effectively cleared the virus from the lungs of infected mice (Table 3). The deficiency in cellular immunity may be attributable to a lack of clonal expansion of CD8+ T cells (Table 1). Furthermore, the decreased production of IFN-, which stimulates virus-specific CD8+ CTL responses, together with the augmented production of IL-4, also correlates with the observed immune deficiency (Bangham et al., 1985; Maggi et al., 1992; Abbas et al., 1996; Lee et al., 2005). Recent studies have shown that overexpression of IL-4 causes a delay and suppression of development of the virus-specific CTL population (Fischer et al., 1997; Aung & Graham, 2000). Immunization of mice with the RSV M2 vaccine construct expressing IL-4 induces a significant downregulation of the RSV-specific CD8+ CTL response, as well as of IFN- production (Tang & Graham, 1994; Aung et al., 1999). These findings are in concert with our concept that the pronounced production of IL-4 in RSV-infected SAM-P1 mice reduces its local CTL response.
RSV-induced CD4+ T cells play a role in virus clearance, but they are not the primary effector cells (Plotnicky-Gilquin et al., 2000). The reduced number of CD4+ T cells in the lungs of RSV-infected SAM-P1 mice was due to an early involution of the thymus (Toichi et al., 1997) and a low efficiency of T-cell proliferation in response to RSV antigens (Table 1). Reduced CD4+ T cells in SAM-P1 mice could cause a weak response of local IgA antibody production (Fig. 5c). Specific antibodies to the attachment (G) and fusion (F) virus envelope proteins are potentially protective (Glezen et al., 1981; Walsh & Falsey, 2004) and contribute to elimination of the progeny virus at a later phase of infection, probably through antibody-dependent immune cytolysis (Hashimoto et al., 1983; Falsey et al., 1999). In particular, the IgA subclass antibody in the upper respiratory tract is important for protection against viruses such as RSV that cause surface infection (Renegar & Small, 1991). The ability of Th1 and Th2 cells to stimulate the production of IgG subclass antibodies was not altered in SAM-P1 mice (Fig. 5a, b).
Pneumonia is characterized by the recruitment of inflammatory cells, mainly granulocytes, to the local site of infection (Skerrett, 1994). The influx of granulocytes into the lung alveolar compartment during RSV infection was markedly increased in SAM-P1 mice (Table 1). The weight loss observed in SAM-P1 mice was consistent with the increased cell infiltration in the lungs (Figs 1 and 3). It is conceivable that the vigorous recruitment of granulocytes, especially at day 3 after infection, was induced by abundant and prolonged virus loading in the lungs (Fig. 2) and triggered the increased morbidity. A significant weight loss with high-titre virus replication in the lung has been observed in old BALB/c mice following infection with a high-inoculum dose of RSV (Graham et al., 1988). Age-dependent RSV replication also occurs in the cotton rat (Curtis et al., 2002). These findings suggest that the inoculum dose of challenge virus and the age of the mouse may be important factors for RSV-induced illness. We suggest that that the early appearance of peak virus titre in SAM-P1 mice at day 3 of infection is related to the high-inoculum dose of RSV and the specific strain of mouse used (Fig. 2).
|
ACKNOWLEDGEMENTS |
|---|
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMETHODSRESULTSDISCUSSIONREFERENCES |
|---|
Abe, Y., Yuasa, M., Kajiwara, Y. & Hosono, M. (1994). Defects of immune cells in the senescence-accelerated mouse: a model for learning and memory deficits in the aged. Cell Immunol 157, 59–69.[CrossRef][Medline]
Aung, S. & Graham, B. S. (2000). IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo. J Immunol 164, 3487–3493.
Aung, S., Tang, Y. W. & Graham, B. S. (1999). Interleukin-4 diminishes CD8+ respiratory syncytial virus-specific cytotixic T-lymphocyte activity in vivo. J Virol 73, 8944–8949.
Bangham, C. R., Cannon, M. J., Karzon, D. T. & Askonas, B. A. (1985). Cytotoxic T-cell response to respiratory syncytial virus in mice. J Virol 56, 55–59.
Boukhvalova, M. S., Yim, K. C., Kuhn, K. H., Hemming, J. P., Prince, G. A., Porter, D. D. & Blance, J. C. (2007). Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment. J Infect Dis 195, 511–518.[CrossRef][Medline]
Curtis, S. J., Ottolini, M. G., Porter, D. D. & Prince, G. A. (2002). Age-dependent replication of respiratory syncytial virus in the cotton rat. Exp Biol Med (Maywood) 227, 799–802.
de Bree, G. J., Heidema, J., van Leeuwen, E. M., van Bleek, G. M., Jonkers, R. E., Jansen, H. M., van Lier, R. A. & Out, T. A. (2005). Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 191, 1710–1718.[CrossRef][Medline]
Decker, T. & Lohmann-Matthes, M. L. (1988). A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115, 61–69.[CrossRef][Medline]
Dong, L., Mori, I., Hossain, M. J. & Kimura, Y. (2000). The senescence-accelerated mouse shows aging-related defects in cellular but not humoral immunity against influenza virus infection. J Infect Dis 182, 391–396.[CrossRef][Medline]
Dowell, S. F., Anderson, L. J., Gary, H. E., Jr, Erdman, D. D., Plouffe, J. F., File, T. M., Jr, Marston, B. J. & Breiman, R. F. (1996). Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis 174, 456–462.[Medline]
Falsey, A. R., Cunningham, C. K., Barker, W. H., Kouides, R. W., Yuen, J. B., Menegus, M., Weiner, L. B., Bonville, C. A. & Betts, R. F. (1995). Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 172, 389–394.[Medline]
Falsey, A. R., Walsh, E. E., Looney, R. J., Kolassa, J. E., Formica, M. A., Criddle, M. C. & Hall, W. J. (1999). Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults. J Med Virol 59, 221–226.[CrossRef][Medline]
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C. & Walsh, E. E. (2005). Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352, 1749–1759.
Fischer, J. E., Johnson, J. E., Kuli-Zade, R. K., Johnson, T. R., Aung, S., Parker, R. A. & Graham, B. S. (1997). Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol 71, 8672–8677.
Glezen, W. P., Paredes, A., Allison, J. E., Taber, L. H. & Frank, A. L. (1981). Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 98, 708–715.[Medline]
Graham, B. S., Perkins, M. D., Wright, P. F. & Karzon, D. T. (1988). Primary respiratory syncytial virus infection in mice. J Med Virol 26, 153–162.[Medline]
Hall, C. B., Powell, K. R., MacDonald, N. E., Gala, C. L., Menegus, M. E., Suffin, S. C. & Cohen, H. J. (1986). Respiratory syncytial virus infection in children with compromised immune function. N Engl J Med 315, 77–81.[Abstract]
Haruna, H., Inaba, M., Inaba, K., Taketani, S., Sugiura, K., Fukuba, Y., Doi, H., Toki, J., Tokunaga, R. & Ikehara, S. (1995). Abnormalities of B cells and dendritic cells in SAMP1 mice. Eur J Immunol 25, 1319–1325.[Medline]
Hashimoto, G., Wright, P. F. & Karzon, D. T. (1983). Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells. J Infect Dis 148, 785–794.[Medline]
Lee, F. E., Walsh, E. E., Falsey, A. R., Liu, N., Liu, D., Divekar, A., Snyder-Cappione, J. E. & Mosmann, T. R. (2005). The balance between influenza- and RSV-specific CD4 T cells secreting IL-10 or IFN- in young and healthy-elderly subjects. Mech Ageing Dev 126, 1223–1229.[CrossRef][Medline]
Liu, B., Mori, I., Hossain, M. J., Dong, L. & Kimura, Y. (2001). Peroral vaccination with a temperature-sensitive mutant of parainfluenza virus type 1 protects mice against respiratory challenge infection. J Gen Virol 82, 2889–2894.
Liu, B., Mori, I., Hossain, M. J., Dong, L., Takeda, K. & Kimura, Y. (2004). Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85, 423–428.
Maggi, E., Parronchi, P., Manetti, R., Simonelli, C., Piccinni, M. P., Rugiu, F. S., De Carli, M., Ricci, M. & Romagnani, S. (1992). Reciprocal regulatory effects of IFN- and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 148, 2142–2147.[Abstract]
Mbawuike, I. N., Lange, A. R. & Couch, R. B. (1993). Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons. Viral Immunol 6, 55–64.[Medline]
Mbawuike, I. N., Acuna, C., Caballero, D., Pham-Nguyen, K., Gilbert, B., Petribon, P. & Harmon, M. (1996). Reversal of age-related deficient influenza virus-specific CTL responses and IFN- production by monophosphoryl lipid A. Cell Immunol 173, 64–78.[CrossRef][Medline]
Miller, R. A. (1996). The aging immune system: primer and prospectus. Science 273, 70–74.[Abstract]
Munoz, J. L., McCarthy, C. A., Clark, M. E. & Hall, C. B. (1991). Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells. J Virol 65, 4494–4497.
Plotnicky-Gilquin, H., Robert, A., Chevalet, L., Haeuw, J. F., Beck, A., Bonnefoy, J. Y., Brandt, C., Siegrist, C. A., Nguyen, T. N. & Power, U. F. (2000). CD4+ T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment. J Virol 74, 3455–3463.
Reed, L. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am J Hyg 27, 493–497.
Renegar, K. B. & Small, P. A., Jr (1991). Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol 65, 2146–2148.
Reuman, P. D., Keely, S. P. & Schiff, G. M. (1990). Rapid recovery in mice after combined nasal/oral immunization with killed respiratory syncytial virus in mice. J Med Virol 32, 67–72.[Medline]
Skerrett, S. J. (1994). Host defenses against respiratory infection. Med Clin North Am 78, 941–966.[Medline]
Tang, Y. W. & Graham, B. S. (1994). Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus. J Clin Invest 94, 1953–1958.[Medline]
Toichi, E., Hanada, K., Hosokawa, T., Higuchi, K., Hosokawa, M., Imamura, S. & Hosono, M. (1997). Age-related decline in humoral immunity caused by the selective loss of TH cells and decline in cellular immunity caused by the impaired migration of inflammatory cells without a loss of TDTH cells in SAMP1 mice. Mech Ageing Dev 99, 199–217.[CrossRef][Medline]
Walsh, E. E. & Falsey, A. R. (2004). Age-related differences in humoral immune response to respiratory syncytial virus infection in adults. J Med Virol 73, 295–299.[CrossRef][Medline]
Walsh, E. E., Falsey, A. R. & Hennessey, P. A. (1999). Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med 160, 791–795.
Zhang, Y., Wang, Y., Gilmore, X., Xu, K., Wyde, P. R. & Mbawuike, I. N. (2002). An aged mouse model for RSV infection and diminished CD8+ CTL responses. Exp Biol Med (Maywood) 227, 133–140.
Received 16 April 2007;
accepted 30 May 2007.
This article has been cited by other articles:
|
|
 |
|
  M. Darniot, C. Pitoiset, T. Petrella, S. Aho, P. Pothier, and C. Manoha Age-Associated Aggravation of Clinical Disease after Primary Metapneumovirus Infection of BALB/c Mice J. Virol., April 1, 2009; 83(7): 3323 - 3332. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
) and SAM-R1 (
) mice were infected intranasally with RSV at an inoculum dose of 2x106 TCID50 per mouse. Data are representative of the results of two independent experiments with five mice per group.
